메뉴 건너뛰기




Volumn 366, Issue 4, 2012, Pages 348-359

Mechanisms of disease: Iron overload in human disease

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEPCIDIN; HFE PROTEIN; IMMUNOGLOBULIN; IRON; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TRANSFERRIN;

EID: 84856292277     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1004967     Document Type: Article
Times cited : (478)

References (102)
  • 1
    • 33846691564 scopus 로고    scopus 로고
    • Iron uptake and metabolism in the new millennium
    • DOI 10.1016/j.tcb.2006.12.003, PII S0962892406003400
    • Dunn LL, Rahmanto YS, Richardson DR. Iron uptake and metabolism in the new millennium. Trends Cell Biol 2007; 17:93-100. (Pubitemid 46199183)
    • (2007) Trends in Cell Biology , vol.17 , Issue.2 , pp. 93-100
    • Dunn, L.L.1    Rahmanto, Y.S.2    Richardson, D.R.3
  • 2
    • 67849087296 scopus 로고    scopus 로고
    • Regulation of intestinal iron absorption: The mucosa takes control?
    • Simpson RJ, McKie AT. Regulation of intestinal iron absorption: the mucosa takes control? Cell Metab 2009;10:84-7.
    • (2009) Cell Metab , vol.10 , pp. 84-87
    • Simpson, R.J.1    McKie, A.T.2
  • 3
    • 58749094789 scopus 로고    scopus 로고
    • Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency
    • Shah YM, Matsubara T, Ito S, Yim SH, Gonzalez FJ. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab 2009;9:152-64.
    • (2009) Cell Metab , vol.9 , pp. 152-164
    • Shah, Y.M.1    Matsubara, T.2    Ito, S.3    Yim, S.H.4    Gonzalez, F.J.5
  • 5
    • 37449009448 scopus 로고    scopus 로고
    • Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum
    • Galy B, Ferring-Appel D, Kaden S, Gröne HJ, Hentze MW. Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab 2008; 7:79-85.
    • (2008) Cell Metab , vol.7 , pp. 79-85
    • Galy, B.1    Ferring-Appel, D.2    Kaden, S.3    Gröne, H.J.4    Hentze, M.W.5
  • 6
    • 34247628002 scopus 로고    scopus 로고
    • Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency
    • DOI 10.1038/nsmb1222, PII NSMB1222
    • Sanchez M, Galy B, Muckenthaler MU, Hentze MW. Iron-regulatory proteins limit hypoxia-inducible factor-2 alpha expression in iron deficiency. Nat Struct Mol Biol 2007;14:420-6. (Pubitemid 46685876)
    • (2007) Nature Structural and Molecular Biology , vol.14 , Issue.5 , pp. 420-426
    • Sanchez, M.1    Galy, B.2    Muckenthaler, M.U.3    Hentze, M.W.4
  • 7
    • 57849147670 scopus 로고    scopus 로고
    • Small-molecule inhibitors of HIF-2a translation link its 5?UTR iron-responsive element to oxygen sensing
    • Zimmer M, Ebert BL, Neil C, et al. Small-molecule inhibitors of HIF-2a translation link its 5?UTR iron-responsive element to oxygen sensing. Mol Cell 2008;32:838-48.
    • (2008) Mol Cell , vol.32 , pp. 838-848
    • Zimmer, M.1    Ebert, B.L.2    Neil, C.3
  • 8
    • 65349126484 scopus 로고    scopus 로고
    • A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression
    • Zhang DL, Hughes RM, Ollivierre- Wilson H, Ghosh MC, Rouault TA. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab 2009;9:461-73.
    • (2009) Cell Metab , vol.9 , pp. 461-473
    • Zhang, D.L.1    Hughes, R.M.2    Ollivierre- Wilson, H.3    Ghosh, M.C.4    Rouault, T.A.5
  • 9
    • 10844258104 scopus 로고    scopus 로고
    • Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
    • DOI 10.1126/science.1104742
    • Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306: 2090-3. (Pubitemid 40007660)
    • (2004) Science , vol.306 , Issue.5704 , pp. 2090-2093
    • Nemeth, E.1    Tuttle, M.S.2    Powelson, J.3    Vaughn, M.D.4    Donovan, A.5    Ward, D.M.6    Ganz, T.7    Kaplan, J.8
  • 10
    • 62649135982 scopus 로고    scopus 로고
    • Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2
    • De Domenico I, Lo E, Ward DM, Kaplan J. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. Proc Natl Acad Sci U S A 2009;106:3800-5.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 3800-3805
    • De Domenico, I.1    Lo, E.2    Ward, D.M.3    Kaplan, J.4
  • 11
    • 82955241072 scopus 로고    scopus 로고
    • Non-transferrin bound iron: A key role in iron overload and iron toxicity
    • August 9 (Epub ahead of print)
    • Brissot P, Ropert M, Le Lan C, Loreal O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 2011 August 9 (Epub ahead of print).
    • (2011) Biochim Biophys Acta
    • Brissot, P.1    Ropert, M.2    Le Lan, C.3    Loreal, O.4
  • 13
    • 0031028178 scopus 로고    scopus 로고
    • Tissue-specific regulation of iron metabolism and heme synthesis: Distinct control mechanisms in erythroid cells
    • Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 1997;89:1-25. (Pubitemid 26428173)
    • (1997) Blood , vol.89 , Issue.1 , pp. 1-25
    • Ponka, P.1
  • 14
    • 0023876497 scopus 로고
    • Iron metabolism in the erythrophagocytosing Kupffer cell
    • Kondo H, Saito K, Grasso JP, Aisen P. Iron metabolism in the erythrophagocytosing Kupffer cell. Hepatology 1988;8: 32-8. (Pubitemid 18092055)
    • (1988) Hepatology , vol.8 , Issue.1 , pp. 32-38
    • Kondo, H.1    Saito, K.2    Grasso, J.P.3    Aisen, P.4
  • 15
    • 0030608152 scopus 로고    scopus 로고
    • The ferritins: Molecular properties, iron storage function and cellular regulation
    • DOI 10.1016/0005-2728(96)00022-9
    • Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996;1275:161-203. (Pubitemid 26248989)
    • (1996) Biochimica et Biophysica Acta - Bioenergetics , vol.1275 , Issue.3 , pp. 161-203
    • Harrison, P.M.1    Arosio, P.2
  • 16
  • 19
    • 82755195789 scopus 로고    scopus 로고
    • Hepcidin in human iron disorders: Diagnostic implications
    • Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011;57:1650-69.
    • (2011) Clin Chem , vol.57 , pp. 1650-1669
    • Kroot, J.J.1    Tjalsma, H.2    Fleming, R.E.3    Swinkels, D.W.4
  • 20
    • 0035896642 scopus 로고    scopus 로고
    • Hepcidin, a urinary antimicrobial peptide synthesized in the liver
    • Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-10.
    • (2001) J Biol Chem , vol.276 , pp. 7806-7810
    • Park, C.H.1    Valore, E.V.2    Waring, A.J.3    Ganz, T.4
  • 22
    • 51649096725 scopus 로고    scopus 로고
    • Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver
    • Kautz L, Meynard D, Monnier A, et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 2008;112:1503-9.
    • (2008) Blood , vol.112 , pp. 1503-1509
    • Kautz, L.1    Meynard, D.2    Monnier, A.3
  • 23
  • 25
    • 63449103712 scopus 로고    scopus 로고
    • BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
    • Andriopoulos B Jr, Corradini E, Xia Y, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 2009;41:482-7.
    • (2009) Nat Genet , vol.41 , pp. 482-487
    • Andriopoulos Jr., B.1    Corradini, E.2    Xia, Y.3
  • 26
    • 46749158788 scopus 로고    scopus 로고
    • Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin
    • Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HY. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 2008;111:5195-204.
    • (2008) Blood , vol.111 , pp. 5195-5204
    • Xia, Y.1    Babitt, J.L.2    Sidis, Y.3    Chung, R.T.4    Lin, H.Y.5
  • 27
    • 33644876815 scopus 로고    scopus 로고
    • A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
    • Wang RH, Li C, Xu X, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005;2:399-409.
    • (2005) Cell Metab , vol.2 , pp. 399-409
    • Wang, R.H.1    Li, C.2    Xu, X.3
  • 29
    • 23644444316 scopus 로고    scopus 로고
    • Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload
    • DOI 10.1172/JCI25683
    • Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 2005;115:2180-6. (Pubitemid 41134159)
    • (2005) Journal of Clinical Investigation , vol.115 , Issue.8 , pp. 2180-2186
    • Niederkofler, V.1    Salie, R.2    Arber, S.3
  • 30
    • 33646370235 scopus 로고    scopus 로고
    • Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
    • Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006;38:531-9.
    • (2006) Nat Genet , vol.38 , pp. 531-539
    • Babitt, J.L.1    Huang, F.W.2    Wrighting, D.M.3
  • 31
    • 39649115776 scopus 로고    scopus 로고
    • The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin Expression
    • DOI 10.1016/j.cmet.2007.11.016, PII S1550413107003737
    • Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab 2008;7:205-14. (Pubitemid 351285524)
    • (2008) Cell Metabolism , vol.7 , Issue.3 , pp. 205-214
    • Schmidt, P.J.1    Toran, P.T.2    Giannetti, A.M.3    Bjorkman, P.J.4    Andrews, N.C.5
  • 32
    • 33749393565 scopus 로고    scopus 로고
    • Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing
    • DOI 10.1074/jbc.C600197200
    • Goswami T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 2006;281: 28494-8. (Pubitemid 44506991)
    • (2006) Journal of Biological Chemistry , vol.281 , Issue.39 , pp. 28494-28498
    • Goswami, T.1    Andrews, N.C.2
  • 33
    • 0034610781 scopus 로고    scopus 로고
    • Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor
    • DOI 10.1038/47417
    • Bennett MJ, Lebrón JA, Bjorkman PJ. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 2000;403:46-53. (Pubitemid 30038514)
    • (2000) Nature , vol.403 , Issue.6765 , pp. 46-53
    • Bennett, M.J.1    Lebron, J.A.2    Bjorkman, P.J.3
  • 34
    • 37549055467 scopus 로고    scopus 로고
    • HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions
    • Chen J, Chloupková M, Gao J, Chapman- Arvedson TL, Enns CA. HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions. J Biol Chem 2007;282:36862-70.
    • (2007) J Biol Chem , vol.282 , pp. 36862-36870
    • Chen, J.1    Chloupková, M.2    Gao, J.3    Chapman- Arvedson, T.L.4    Enns, C.A.5
  • 35
    • 60649103774 scopus 로고    scopus 로고
    • Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression
    • Gao J, Chen J, Kramer M, Tsukamoto H, Zhang AS, Enns CA. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab 2009;9:217-27.
    • (2009) Cell Metab , vol.9 , pp. 217-227
    • Gao, J.1    Chen, J.2    Kramer, M.3    Tsukamoto, H.4    Zhang, A.S.5    Enns, C.A.6
  • 36
    • 70350494274 scopus 로고    scopus 로고
    • BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression
    • Kautz L, Meynard D, Besson-Fournier C, et al. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. Blood 2009;114: 2515-20.
    • (2009) Blood , vol.114 , pp. 2515-2520
    • Kautz, L.1    Meynard, D.2    Besson-Fournier, C.3
  • 37
    • 70349494083 scopus 로고    scopus 로고
    • Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis
    • Corradini E, Garuti C, Montosi G, et al. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Gastroenterology 2009;137:1489-97.
    • (2009) Gastroenterology , vol.137 , pp. 1489-1497
    • Corradini, E.1    Garuti, C.2    Montosi, G.3
  • 38
    • 78149271252 scopus 로고    scopus 로고
    • Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling: Implications for transferrin-dependent hepcidin regulation
    • Poli M, Luscieti S, Gandini V, et al. Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling: implications for transferrin-dependent hepcidin regulation. Haematologica 2010;95: 1832-40.
    • (2010) Haematologica , vol.95 , pp. 1832-1840
    • Poli, M.1    Luscieti, S.2    Gandini, V.3
  • 39
    • 73149083742 scopus 로고    scopus 로고
    • Combined deletion of HFE and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload
    • Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN. Combined deletion of HFE and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 2009;50:1992- 2000.
    • (2009) Hepatology , vol.50 , pp. 1992-2000
    • Wallace, D.F.1    Summerville, L.2    Crampton, E.M.3    Frazer, D.M.4    Anderson, G.J.5    Subramaniam, V.N.6
  • 41
    • 58149399349 scopus 로고    scopus 로고
    • Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I
    • Tamary H, Shalev H, Perez-Avraham G, et al. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood 2008;112:5241-4.
    • (2008) Blood , vol.112 , pp. 5241-5244
    • Tamary, H.1    Shalev, H.2    Perez-Avraham, G.3
  • 42
    • 80052430244 scopus 로고    scopus 로고
    • Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II
    • Berl
    • Casanovas G, Swinkels DW, Altamura S, et al. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II. J Mol Med (Berl) 2011;89:811-6.
    • (2011) J Mol Med , vol.89 , pp. 811-816
    • Casanovas, G.1    Swinkels, D.W.2    Altamura, S.3
  • 43
    • 67651043722 scopus 로고    scopus 로고
    • Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells
    • Tanno T, Porayette P, Sripichai O, et al. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 2009;114:181-6.
    • (2009) Blood , vol.114 , pp. 181-186
    • Tanno, T.1    Porayette, P.2    Sripichai, O.3
  • 44
    • 78751598932 scopus 로고    scopus 로고
    • Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: New link between hypoxia signaling and iron homeostasis
    • Lakhal S, Schödel J, Townsend ARM, Pugh CW, Ratcliffe PJ, Mole DR. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis. J Biol Chem 2011; 286:4090-7.
    • (2011) J Biol Chem , vol.286 , pp. 4090-4097
    • Lakhal, S.1    Schödel, J.2    Townsend, A.R.M.3    Pugh, C.W.4    Ratcliffe, P.J.5    Mole, D.R.6
  • 45
    • 56449096622 scopus 로고    scopus 로고
    • The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin
    • Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 2008; 8:502-11.
    • (2008) Cell Metab , vol.8 , pp. 502-511
    • Silvestri, L.1    Pagani, A.2    Nai, A.3    De Domenico, I.4    Kaplan, J.5    Camaschella, C.6
  • 46
    • 38349194098 scopus 로고    scopus 로고
    • Furin-mediated release of soluble hemojuvelin: A new link between hypoxia and iron homeostasis
    • Silvestri L, Pagani A, Camaschella C. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 2008;111:924-31.
    • (2008) Blood , vol.111 , pp. 924-931
    • Silvestri, L.1    Pagani, A.2    Camaschella, C.3
  • 47
    • 75149190912 scopus 로고    scopus 로고
    • Iron homeostasis and its interaction with prolyl hydroxylases
    • Mole DR. Iron homeostasis and its interaction with prolyl hydroxylases. Antioxid Redox Signal 2010;12:445-58.
    • (2010) Antioxid Redox Signal , vol.12 , pp. 445-458
    • Mole, D.R.1
  • 48
    • 67651146945 scopus 로고    scopus 로고
    • HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis- related morbidity
    • Gurrin LC, Bertalli NA, Dalton GW, et al. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis- related morbidity. Hepatology 2009;50: 94-101.
    • (2009) Hepatology , vol.50 , pp. 94-101
    • Gurrin, L.C.1    Bertalli, N.A.2    Dalton, G.W.3
  • 50
    • 0035353167 scopus 로고    scopus 로고
    • New mutations inactivating transferrin receptor 2 in hemochromatosis type 3
    • Roetto A, Totaro A, Piperno A, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001;97:2555-60.
    • (2001) Blood , vol.97 , pp. 2555-2560
    • Roetto, A.1    Totaro, A.2    Piperno, A.3
  • 54
    • 32544437693 scopus 로고    scopus 로고
    • Iron overload due to mutations in ferroportin
    • De Domenico I, Ward DM, Musci G, Kaplan J. Iron overload due to mutations in ferroportin. Haematologica 2006;91:92-5. (Pubitemid 43235391)
    • (2006) Haematologica , vol.91 , Issue.1 , pp. 92-95
    • De Domenico, I.1    Ward, D.M.2    Musci, G.3    Kaplan, J.4
  • 55
    • 67651087324 scopus 로고    scopus 로고
    • The molecular basis of hepcidin-resistant hereditary hemochromatosis
    • Fernandes A, Preza GC, Phung Y, et al. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 2009; 114:437-43.
    • (2009) Blood , vol.114 , pp. 437-443
    • Fernandes, A.1    Preza, G.C.2    Phung, Y.3
  • 57
    • 33644873239 scopus 로고    scopus 로고
    • Ferroportin (Q248H) mutations in African families with dietary iron overload
    • DOI 10.1111/j.1440-1746.2005.03930.x
    • McNamara L, Gordeuk VR, MacPhail AP. Ferroportin (Q248H) mutations in African families with dietary iron overload. J Gastroenterol Hepatol 2005;20:1855-8. (Pubitemid 43961041)
    • (2005) Journal of Gastroenterology and Hepatology , vol.20 , Issue.12 , pp. 1855-1858
    • McNamara, L.1    Gordeuk, V.R.2    MacPhail, A.P.3
  • 58
    • 33745743014 scopus 로고    scopus 로고
    • Hepcidin and iron-loading anemias
    • Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006;91: 727-32. (Pubitemid 44014536)
    • (2006) Haematologica , vol.91 , Issue.6 , pp. 727-732
    • Nemeth, E.1    Ganz, T.2
  • 59
    • 78651378996 scopus 로고    scopus 로고
    • Iron-chelating therapy for transfusional iron overload
    • Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med 2011;364:146-56.
    • (2011) N Engl J Med , vol.364 , pp. 146-156
    • Brittenham, G.M.1
  • 60
    • 77955915545 scopus 로고    scopus 로고
    • Pathogenesis and management of iron toxicity in thalassemia
    • Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci 2010;1202:1-9.
    • (2010) Ann N Y Acad Sci , vol.1202 , pp. 1-9
    • Hershko, C.1
  • 61
    • 76349118307 scopus 로고    scopus 로고
    • Transferrin therapy ameliorates disease in beta-thalassemic mice
    • Li H, Rybicki AC, Suzuka SM, et al. Transferrin therapy ameliorates disease in beta-thalassemic mice. Nat Med 2010; 16:177-82.
    • (2010) Nat Med , vol.16 , pp. 177-182
    • Li, H.1    Rybicki, A.C.2    Suzuka, S.M.3
  • 62
    • 78649813036 scopus 로고    scopus 로고
    • Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice
    • Gardenghi S, Ramos P, Marongiu MF, et al. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice. J Clin Invest 2010; 120:4466-77.
    • (2010) J Clin Invest , vol.120 , pp. 4466-4477
    • Gardenghi, S.1    Ramos, P.2    Marongiu, M.F.3
  • 63
    • 79959262524 scopus 로고    scopus 로고
    • Prospects for a hepcidin mimic to treat beta-thalassemia and hemochromatosis
    • Parrow NL, Gardenghi S, Rivella S. Prospects for a hepcidin mimic to treat beta-thalassemia and hemochromatosis. Expert Rev Hematol 2011;4:233-5.
    • (2011) Expert Rev Hematol , vol.4 , pp. 233-235
    • Parrow, N.L.1    Gardenghi, S.2    Rivella, S.3
  • 64
    • 0036799489 scopus 로고    scopus 로고
    • The genetics of inherited sideroblastic anemias
    • DOI 10.1053/shem.2002.35637
    • Fleming MD. The genetics of inherited sideroblastic anemias. Semin Hematol 2002;39:270-81. (Pubitemid 35192640)
    • (2002) Seminars in Hematology , vol.39 , Issue.4 , pp. 270-281
    • Fleming, M.D.1
  • 66
    • 39749126765 scopus 로고    scopus 로고
    • Iron overload in myelodysplastic syndromes
    • DOI 10.1080/10428190701843221, PII 790366266
    • Mahesh S, Ginzburg Y, Verma A. Iron overload in myelodysplastic syndromes. Leuk Lymphoma 2008;49:427-38. (Pubitemid 351298326)
    • (2008) Leukemia and Lymphoma , vol.49 , Issue.3 , pp. 427-438
    • Mahesh, S.1    Ginzburg, Y.2    Verma, A.3
  • 67
    • 0034585942 scopus 로고    scopus 로고
    • Biochemical and genetic defects underlying human congenital hypotransferrinemia
    • Goldwurm S, Casati C, Venturi N, et al. Biochemical and genetic defects underlying human congenital hypotransferrinemia. Hematol J 2000;1:390-8.
    • (2000) Hematol J , vol.1 , pp. 390-398
    • Goldwurm, S.1    Casati, C.2    Venturi, N.3
  • 68
    • 36348972935 scopus 로고    scopus 로고
    • Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia
    • DOI 10.3324/haematol.11377
    • Trombini P, Coliva T, Nemeth E, et al. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Haematologica 2007;92: 1407-10. (Pubitemid 350144159)
    • (2007) Haematologica , vol.92 , Issue.10 , pp. 1407-1410
    • Trombini, P.1    Coliva, T.2    Nemeth, E.3    Mariani, R.4    Ganz, T.5    Biondi, A.6    Piperno, A.7
  • 69
    • 78751558997 scopus 로고    scopus 로고
    • Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice
    • Bartnikas TB, Andrews NC, Fleming MD. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. Blood 2011;117:630-7.
    • (2011) Blood , vol.117 , pp. 630-637
    • Bartnikas, T.B.1    Andrews, N.C.2    Fleming, M.D.3
  • 70
    • 0031981976 scopus 로고    scopus 로고
    • Aceruloplasminemia: An inherited neurodegenerative disease with impairment of iron homeostasis
    • Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 1998;67:5 Suppl:972S-977S. (Pubitemid 28198819)
    • (1998) American Journal of Clinical Nutrition , vol.67 , Issue.5 SUPPL.
    • Harris, Z.L.1    Klomp, L.W.J.2    Gitlin, J.D.3
  • 72
    • 0034795445 scopus 로고    scopus 로고
    • Neonatal hemochromatosis
    • DOI 10.1542/peds.108.4.960
    • Murray KF, Kowdley KV. Neonatal hemochromatosis. Pediatrics 2001;108: 960-4. (Pubitemid 32947667)
    • (2001) Pediatrics , vol.108 , Issue.4 , pp. 960-964
    • Murray, K.F.1    Kowdley, K.V.2
  • 73
    • 34548127283 scopus 로고    scopus 로고
    • Neonatal hemochromatosis: A congenital alloimmune hepatitis
    • DOI 10.1055/s-2007-985069
    • Whitington PF. Neonatal hemochromatosis: a congenital alloimmune hepatitis. Semin Liver Dis 2007;27:243-50. (Pubitemid 47301764)
    • (2007) Seminars in Liver Disease , vol.27 , Issue.3 , pp. 243-250
    • Whitington, P.F.1
  • 74
    • 70249151112 scopus 로고    scopus 로고
    • Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin
    • Rand EB, Karpen SJ, Kelly S, et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr 2009;155: 566-71.
    • (2009) J Pediatr , vol.155 , pp. 566-571
    • Rand, E.B.1    Karpen, S.J.2    Kelly, S.3
  • 75
    • 7644235252 scopus 로고    scopus 로고
    • High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis
    • DOI 10.1016/S0140-6736(04)17356-X, PII S014067360417356X
    • Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 2004;364:1690-8. (Pubitemid 39458145)
    • (2004) Lancet , vol.364 , Issue.9446 , pp. 1690-1698
    • Whitington, P.F.1    Hibbard, J.U.2
  • 76
    • 79958032358 scopus 로고    scopus 로고
    • Deoxyguanosine kinase deficiency presenting as neonatal hemochromatosis
    • Hanchard NA, Shchelochkov OA, Roy A, et al. Deoxyguanosine kinase deficiency presenting as neonatal hemochromatosis. Mol Genet Metab 2011;103:262-7.
    • (2011) Mol Genet Metab , vol.103 , pp. 262-267
    • Hanchard, N.A.1    Shchelochkov, O.A.2    Roy, A.3
  • 77
    • 2342435003 scopus 로고    scopus 로고
    • Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration
    • DOI 10.1002/mds.10650
    • Thomas M, Hayflick SJ, Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord 2004;19:36-42. (Pubitemid 38559618)
    • (2004) Movement Disorders , vol.19 , Issue.1 , pp. 36-42
    • Thomas, M.1    Hayflick, S.J.2    Jankovic, J.3
  • 78
    • 79954460490 scopus 로고    scopus 로고
    • Childhood disorders of neurodegeneration with brain iron accumulation (NBIA)
    • Kurian MA, McNeill A, Lin JP, Maher ER. Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev Med Child Neurol 2011;53: 394-404.
    • (2011) Dev Med Child Neurol , vol.53 , pp. 394-404
    • Kurian, M.A.1    McNeill, A.2    Lin, J.P.3    Maher, E.R.4
  • 79
    • 0034935036 scopus 로고    scopus 로고
    • A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
    • DOI 10.1038/ng572
    • Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-9. (Pubitemid 32702423)
    • (2001) Nature Genetics , vol.28 , Issue.4 , pp. 345-349
    • Zhou, B.1    Westaway, S.K.2    Levinson, B.3    Johnson, M.A.4    Gitschier, J.5    Hayflick, S.J.6
  • 82
    • 33750709690 scopus 로고    scopus 로고
    • Brain Iron Metabolism
    • DOI 10.1016/j.spen.2006.08.002, PII S107190910600101X
    • Rouault TA, Cooperman S. Brain iron metabolism. Semin Pediatr Neurol 2006; 13:142-8. (Pubitemid 44709651)
    • (2006) Seminars in Pediatric Neurology , vol.13 , Issue.3 , pp. 142-148
    • Rouault, T.A.1    Cooperman, S.2
  • 83
    • 43049150678 scopus 로고    scopus 로고
    • Metals in Alzheimer's and Parkinson's diseases
    • Barnham KJ, Bush AI. Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol 2008;12:222-8.
    • (2008) Curr Opin Chem Biol , vol.12 , pp. 222-228
    • Barnham, K.J.1    Bush, A.I.2
  • 84
    • 0035122450 scopus 로고    scopus 로고
    • Frataxin: Its role in iron metabolism and the pathogenesis of Friedreich's ataxia
    • DOI 10.1016/S1357-2725(00)00067-4, PII S1357272500000674
    • Becker E, Richardson DR. Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia. Int J Biochem Cell Biol 2001;33:1-10. (Pubitemid 32146462)
    • (2001) International Journal of Biochemistry and Cell Biology , vol.33 , Issue.1 , pp. 1-10
    • Becker, E.1    Richardson, D.R.2
  • 85
    • 77954627973 scopus 로고    scopus 로고
    • Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol
    • Richardson DR, Lane DJ, Becker EM, et al. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A 2010;107:10775-82.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 10775-10782
    • Richardson, D.R.1    Lane, D.J.2    Becker, E.M.3
  • 87
    • 85045841958 scopus 로고    scopus 로고
    • Hemochromatosis and vitamin C
    • Herbert V. Hemochromatosis and vitamin C. Ann Intern Med 1999;131:475-6.
    • (1999) Ann Intern Med , vol.131 , pp. 475-476
    • Herbert, V.1
  • 88
    • 80051800854 scopus 로고    scopus 로고
    • IRon overload screeNing tool (IRON): Development of a tool to guide screening in primary care
    • Mainous AG III, Diaz VA, Everett CJ, et al. IRon overload screeNing tool (IRON): development of a tool to guide screening in primary care. Am J Hematol 2011;86: 733-7.
    • (2011) Am J Hematol , vol.86 , pp. 733-737
    • Mainous III, A.G.1    Diaz, V.A.2    Everett, C.J.3
  • 91
    • 62949152341 scopus 로고    scopus 로고
    • Towards explaining "unexplained hyperferritinemia."
    • Camaschella C, Poggiali E. Towards explaining "unexplained hyperferritinemia." Haematologica 2009;94:307-9.
    • (2009) Haematologica , vol.94 , pp. 307-309
    • Camaschella, C.1    Poggiali, E.2
  • 94
  • 96
    • 73949096220 scopus 로고    scopus 로고
    • Iron overload: Consequences, assessment, and monitoring
    • Taher AT, Musallam KM, Inati A. Iron overload: consequences, assessment, and monitoring. Hemoglobin 2009;33:Suppl 1: S46-S47.
    • (2009) Hemoglobin , vol.33 , Issue.SUPPL. 1
    • Taher, A.T.1    Musallam, K.M.2    Inati, A.3
  • 97
    • 0014465766 scopus 로고
    • Alteration in cobalt absorption in patients with disorders of iron metabolism
    • Valberg LS, Ludwig J, Olatunbosun D. Alteration in cobalt absorption in patients with disorders of iron metabolism. Gastroenterology 1969;56:241-51.
    • (1969) Gastroenterology , vol.56 , pp. 241-251
    • Valberg, L.S.1    Ludwig, J.2    Olatunbosun, D.3
  • 100
    • 24744458603 scopus 로고    scopus 로고
    • Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs
    • DOI 10.1182/blood-2005-04-1766
    • Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin- containing organs. Blood 2005; 106:2196-9. (Pubitemid 41291740)
    • (2005) Blood , vol.106 , Issue.6 , pp. 2196-2199
    • Rivera, S.1    Nemeth, E.2    Gabayan, V.3    Lopez, M.A.4    Farshidi, D.5    Ganz, T.6
  • 102
    • 78649634981 scopus 로고    scopus 로고
    • Hepcidin in human iron disorders: Therapeutic implications
    • Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J Hepatol 2011;54:173-81.
    • (2011) J Hepatol , vol.54 , pp. 173-181
    • Pietrangelo, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.